MGX-12082-64439
4 vaccinations
5 coded responses
36 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 972 / OR
- Registered
- 2021-01-02
- Relationship
- Self
- Race
- White
- Ethnicity
- N/A
Registered dependents
MMJ-18776-52121
Child or adolescent in my care · Female · 2022-06-25
Timeline
-
2020-12-29
Dose 1 — Moderna
-
2021-01-02
Registered in v-safe
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-05
-
2021-01-12
Survey response — day 14, dose 1MedDRA: Injection site erythema, Injection site induration — Feeling: GoodFree text: Redness and hardness at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-20
- 2021-01-26
-
2021-01-27
Dose 2 — Moderna
- 2021-01-27
-
2021-01-28
Survey response — days 1–6 daily, dose 2MedDRA: Throat irritation — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Scratchy throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-29
- 2021-01-30
- 2021-01-31
- 2021-02-02
- 2021-02-03
- 2021-02-10
- 2021-02-19
- 2021-02-24
- 2021-03-03
- 2021-03-10
- 2021-04-30
-
2021-07-28
Survey response — 6 months, dose 2MedDRA: Abdominal discomfort, Nasopharyngitis, Oropharyngeal pain — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Head cold, sore throat, gi upsetMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-11-19
Dose 3 — Moderna
- 2022-01-27
-
2022-10-14
Dose 4 — Pfizer-BioNTech
- 2022-10-14
- 2022-10-15
- 2022-10-16
- 2022-10-17
- 2022-10-18
- 2022-10-19
- 2022-10-20
- 2022-10-23
- 2022-10-28
- 2022-11-06
-
2022-11-11
Survey response — day 28, dose 4MedDRA: Headache, Nasal congestion, Oropharyngeal pain — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Sore throat, nasal congestion, headacheMedDRA releases: 2024-11 · check-in free text available
- 2022-11-18
- 2022-11-27
- 2023-01-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-29 | Moderna | |
| 2 | 2021-01-27 | Moderna | |
| 3 | 2021-11-19 | Moderna | No |
| 4 | 2022-10-14 | Pfizer-BioNTech | No |
Free text
Release 1 — day 14, dose 1
Symptoms: Redness and hardness at injection site
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Scratchy throat
Release 9 — 6 months, dose 2
Symptoms: Head cold, sore throat, gi upset
Release 12 — day 28, dose 4
Symptoms: Sore throat, nasal congestion, headache
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal discomfort | ✓ | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Injection site erythema | ✓ | ✓ | ✓ |
| SD | Injection site induration | ✓ | ✓ | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nasopharyngitis | ✓ | · | ✓ |
| SD | Oropharyngeal pain | ✓ | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SRO | Throat irritation | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release